These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 19918946)

  • 21. Characterization of class I MHC folding intermediates and their disparate interactions with peptide and beta 2-microglobulin.
    Smith JD; Solheim JC; Carreno BM; Hansen TH
    Mol Immunol; 1995 May; 32(7):531-40. PubMed ID: 7783756
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression and characterization of recombinant single-chain salmon class I MHC fused with beta2-microglobulin with biological activity.
    Zhao H; Stet RJ; Skjødt K; Savelkoul HF
    Fish Shellfish Immunol; 2008 Apr; 24(4):459-66. PubMed ID: 18280180
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MHC-Peptide Tetramers to Visualize Antigen-Specific T Cells.
    Altman JD; Davis MM
    Curr Protoc Immunol; 2016 Nov; 115():17.3.1-17.3.44. PubMed ID: 27801510
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cutting edge: single-chain trimers of MHC class I molecules form stable structures that potently stimulate antigen-specific T cells and B cells.
    Yu YY; Netuschil N; Lybarger L; Connolly JM; Hansen TH
    J Immunol; 2002 Apr; 168(7):3145-9. PubMed ID: 11907065
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Peptide-independent stabilization of MHC class I molecules breaches cellular quality control.
    Hein Z; Uchtenhagen H; Abualrous ET; Saini SK; Janßen L; Van Hateren A; Wiek C; Hanenberg H; Momburg F; Achour A; Elliott T; Springer S; Boulanger D
    J Cell Sci; 2014 Jul; 127(Pt 13):2885-97. PubMed ID: 24806963
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Xenogeneic beta 2-microglobulin substitution affects functional binding of MHC class I molecules by CD8+ T cells.
    Benoit LA; Tan R
    J Immunol; 2007 Sep; 179(6):3588-95. PubMed ID: 17785793
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chimeric beta2 microglobulin/CD3zeta polypeptides expressed in T cells convert MHC class I peptide ligands into T cell activation receptors: a potential tool for specific targeting of pathogenic CD8(+) T cells.
    Margalit A; Fishman S; Berko D; Engberg J; Gross G
    Int Immunol; 2003 Nov; 15(11):1379-87. PubMed ID: 14565936
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Peptide-induced conformational change of the class I heavy chain.
    Elliott T; Cerundolo V; Elvin J; Townsend A
    Nature; 1991 May; 351(6325):402-6. PubMed ID: 2034289
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A yeast display system for engineering functional peptide-MHC complexes.
    Brophy SE; Holler PD; Kranz DM
    J Immunol Methods; 2003 Jan; 272(1-2):235-46. PubMed ID: 12505727
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dimerization of soluble disulfide trap single-chain major histocompatibility complex class I molecules dependent on peptide binding affinity.
    Kotsiou E; Brzostek J; Lenart I; Antoniou AN; Dyson J; Gould KG
    Antioxid Redox Signal; 2011 Aug; 15(3):635-44. PubMed ID: 21050141
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structural basis of the CD8 alpha beta/MHC class I interaction: focused recognition orients CD8 beta to a T cell proximal position.
    Wang R; Natarajan K; Margulies DH
    J Immunol; 2009 Aug; 183(4):2554-64. PubMed ID: 19625641
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dynamics of free versus complexed β2-microglobulin and the evolution of interfaces in MHC class I molecules.
    Hee CS; Beerbaum M; Loll B; Ballaschk M; Schmieder P; Uchanska-Ziegler B; Ziegler A
    Immunogenetics; 2013 Mar; 65(3):157-72. PubMed ID: 23229474
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Invariant chain association with MHC class I: preference for HLA class I/beta 2-microglobulin heterodimers, specificity, and influence of the MHC peptide-binding groove.
    Vigna JL; Smith KD; Lutz CT
    J Immunol; 1996 Nov; 157(10):4503-10. PubMed ID: 8906828
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CH/pi interactions in the crystal structure of class I MHC antigens and their complexes with peptides.
    Umezawa Y; Nishio M
    Bioorg Med Chem; 1998 Dec; 6(12):2507-15. PubMed ID: 9925306
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structural Definition of Duck Major Histocompatibility Complex Class I Molecules That Might Explain Efficient Cytotoxic T Lymphocyte Immunity to Influenza A Virus.
    Wu Y; Wang J; Fan S; Chen R; Liu Y; Zhang J; Yuan H; Liang R; Zhang N; Xia C
    J Virol; 2017 Jul; 91(14):. PubMed ID: 28490583
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An extensive region of an MHC class I alpha 2 domain loop influences interaction with the assembly complex.
    Yu YY; Turnquist HR; Myers NB; Balendiran GK; Hansen TH; Solheim JC
    J Immunol; 1999 Oct; 163(8):4427-33. PubMed ID: 10510384
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficient generation of major histocompatibility complex class I-peptide complexes using synthetic peptide libraries.
    Stevens J; Wiesmüller KH; Barker PJ; Walden P; Butcher GW; Joly E
    J Biol Chem; 1998 Jan; 273(5):2874-84. PubMed ID: 9446598
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An in vitro study of the dynamic features of the major histocompatibility complex class I complex relevant to its role as a versatile peptide-receptive molecule.
    Hörig H; Papadopoulos NJ; Vegh Z; Palmieri E; Angeletti RH; Nathenson SG
    Proc Natl Acad Sci U S A; 1997 Dec; 94(25):13826-31. PubMed ID: 9391112
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A dominant negative mutant beta 2-microglobulin blocks the extracellular folding of a major histocompatibility complex class I heavy chain.
    Hill DM; Kasliwal T; Schwarz E; Hebert AM; Chen T; Gubina E; Zhang L; Kozlowski S
    J Biol Chem; 2003 Feb; 278(8):5630-8. PubMed ID: 12454016
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Peptide binding to MHC class I molecules: implications for antigenic peptide prediction.
    Parker KC; Shields M; DiBrino M; Brooks A; Coligan JE
    Immunol Res; 1995; 14(1):34-57. PubMed ID: 7561340
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.